Glucagon-Like Peptide 1 Receptor Agonists and Risk of Diabetic Retinopathy Complications: Cohort Study in Nationwide Registers From Two Countries

dc.contributor.author	Ueda, Peter
dc.contributor.author	Pasternak, Björn
dc.contributor.author	Eliasson, Björn
dc.contributor.author	Svensson, Ann-Marie
dc.contributor.author	Franzén, Stefan
dc.contributor.author	Gudbjörnsdóttir, Soffia
dc.contributor.author	Hveem, Kristian
dc.contributor.author	Jonasson, Christian
dc.contributor.author	Melbye, Mads
dc.contributor.author	Svanström, Henrik
dc.date.accessioned	2022-07-26T12:59:59Z
dc.date.available	2022-07-26T12:59:59Z
dc.date.created	2020-01-22T10:46:08Z
dc.date.issued	2019
dc.identifier.issn	0149-5992
dc.identifier.uri	https://hdl.handle.net/11250/3008593
dc.language.iso	eng
dc.title	Glucagon-Like Peptide 1 Receptor Agonists and Risk of Diabetic Retinopathy Complications: Cohort Study in Nationwide Registers From Two Countries
dc.type	Peer reviewed
dc.type	Journal article
dc.source.journal	Diabetes Care
dc.identifier.doi	10.2337/dc18-2532
dc.identifier.cristin	1779815
cristin.unitcode	7502,5,0,0
cristin.unitname	Helsedata og digitalisering
cristin.ispublished	true
cristin.qualitycode	1